Correlation between S100B and severity of depression in MDD: A meta-analysis

References

• Agelink MW, Andrich J, Postert T, Würzinger U, Zeit T, Klotz P, Przuntek H. 2001. Relation between electroconvulsive therapy, cognitive side effects, neuron specific enolase, and protein S-100. J Neurol Neurosurg Psychiatry. 71(3):394–396.
   PubMed Web of Science ®Google Scholar
• Aleksovska K, Leoncini E, Bonassi S, Cesario A, Boccia S, Frustaci A. 2014. Systematic review and meta-analysis of circulating S100B blood levels in schizophrenia. PLOS One. 9(9):e106342.
   PubMed Web of Science ®Google Scholar
• Ambrée O, Bergink V, Grosse L, Alferink J, Drexhage HA, Rothermundt M, Arolt V, Birkenhäger TK. 2015. S100B serum levels predict treatment response in patients with melancholic depression. Int J Neuropsychopharmacol. 19(3):pyv103.
   PubMed Web of Science ®Google Scholar
• Andreazza AC, Cassini C, Rosa AR, Leite MC, de Almeida LMV, Nardin P, Cunha ABN, Ceresér KM, Santin A, Gottfried C, et al. 2007. Serum S100B and antioxidant enzymes in bipolar patients. J Psychiatr Res. 41(6):523–529.
   PubMed Web of Science ®Google Scholar
• Arolt V, Peters M, Erfurth A, Wiesmann M, Missler U, Rudolf S, Kirchner H, Rothermundt M. 2003. S100B and response to treatment in major depression: a pilot study. Eur Neuropsychopharmacol. 13(4):235–239.
   PubMed Web of Science ®Google Scholar
• Arora P, Sagar R, Mehta M, Pallavi P, Sharma S, Mukhopadhyay AK. 2019. Serum S100B levels in patients with depression. Indian J Psychiatry. 61(1):70–76.
   PubMed Web of Science ®Google Scholar
• Balduzzi S, Rücker G, Schwarzer G. 2019. How to perform a meta-analysis with R: a practical tutorial. Evid Based Ment Health. 22(4):153–160.
   PubMed Web of Science ®Google Scholar
• Bartoli F, Misiak B, Crocamo C, Carrà G. 2020. Glial and neuronal markers in bipolar disorder: A meta-analysis testing S100B and NSE peripheral blood levels. Prog Neuro Psychopharm Biol Psychiatry. 101:109922.
   PubMed Web of Science ®Google Scholar
• Belleau EL, Treadway MT, Pizzagalli DA. 2019. The impact of stress and major depressive disorder on hippocampal and medial prefrontal cortex morphology. Biol Psychiatry. 85(6):443–453.
   PubMed Web of Science ®Google Scholar
• Businaro R, Leone S, Fabrizi C, Sorci G, Donato R, Lauro GM, Fumagalli L. 2006. S100B protects LAN-5 neuroblastoma cells against Abeta amyloid-induced neurotoxicity via RAGE engagement at low doses but increases Abeta amyloid neurotoxicity at high doses. J Neurosci Res. 83(5):897–906.
   PubMed Web of Science ®Google Scholar
• Carlier A, Boers K, Veerhuis R, Bouckaert F, Sienaert P, Eikelenboom P, Vandenbulcke M, Stek ML, van Exel E, Dols A, et al. 2019. S100 calcium-binding protein B in older patients with depression treated with electroconvulsive therapy. Psychoneuroendocrinology. 110:104414.
   PubMed Web of Science ®Google Scholar
• Chaudhuri JR, Mridula KR, Rathnakishore C, Anamika A, Samala NR, Balaraju B, Bandaru VS. 2021. Association serum S100B protein in Alzheimer’s disease: a case control study from South India. CAR. 17(12):1095–1101.
   Google Scholar
• Chen S, Tian L, Chen N, Xiu M, Wang Z, Yang G, Wang C, Yang F, Tan Y. 2017. Cognitive dysfunction correlates with elevated serum S100B concentration in drug-free acutely relapsed patients with schizophrenia. Psychiatry Res. 247:6–11.
   PubMed Web of Science ®Google Scholar
• Christl J, Verhülsdonk S, Pessanha F, Menge T, Seitz RJ, Kujovic M, Höft B, Supprian T, Lange-Asschenfeldt C. 2019. Association of cerebrospinal fluid S100B protein with core biomarkers and cognitive deficits in prodromal and mild Alzheimer's disease. J Alzheimers Dis. 72(4):1119–1127.
   PubMed Web of Science ®Google Scholar
• Cookey J, Bernier D, Tibbo PG. 2014. White matter changes in early phase schizophrenia and cannabis use: an update and systematic review of diffusion tensor imaging studies. Schizophr Res. 156(2–3):137–142.
   PubMed Web of Science ®Google Scholar
• da Rosa MI, Simon C, Grande AJ, Barichello T, Oses JP, Quevedo J. 2016. Serum S100B in manic bipolar disorder patients: systematic review and meta-analysis. J Affect Disord. 206:210–215.
   PubMed Web of Science ®Google Scholar
• Fang Y, Xiao S-F, Zhang S-Y, Qiu Q, Wang T, Li X. 2016. Increased plasma S100 β level in patients with major depressive disorder. CNS Neurosci Ther. 22(3):248–250.
   PubMed Web of Science ®Google Scholar
• Gilpin AR. 1993. Table for conversion of Kendall’S Tau to Spearman’S Rho within the context of measures of magnitude of effect for meta-analysis. Educ Psychol Meas. 53(1):87–92.
   Web of Science ®Google Scholar
• Griffin WS, Stanley LC, Ling C, White L, MacLeod V, Perrot LJ, White CL, Araoz C. 1989. Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc Natl Acad Sci USA. 86(19):7611–7615.
   PubMed Web of Science ®Google Scholar
• Güleş E, Iosifescu DV, Tural Ü. Ü. 2020. Plasma neuronal and glial markers and anterior cingulate metabolite levels in major depressive disorder: a pilot study. Neuropsychobiology. 79(3):214–221.
   PubMed Web of Science ®Google Scholar
• Hercher C, Chopra V, Beasley C. 2014. Evidence for morphological alterations in prefrontal white matter glia in schizophrenia and bipolar disorder. J Psychiatry Neurosci. 39(6):376–385.
   PubMed Web of Science ®Google Scholar
• Hetzel G, Moeller O, Evers S, Erfurth A, Ponath G, Arolt V, Rothermundt M. 2005. The astroglial protein S100B and visually evoked event-related potentials before and after antidepressant treatment. Psychopharmacology (Berl)). 178(2–3):161–166.
   PubMed Web of Science ®Google Scholar
• Hidese S, Hattori K, Sasayama D, Tsumagari T, Miyakawa T, Matsumura R. 2020. Cerebrospinal fluid neuroplasticity-associated protein levels in patients with psychiatric disorders: a multiplex immunoassay study. Transl Psychiatry. 10(1):161.
   PubMed Web of Science ®Google Scholar
• Jang B-S, Kim H, Lim S-W, Jang K-W, Kim D-K. 2008. Serum S100B levels and major depressive disorder: Its characteristics and role in antidepressant response. Psychiatry Investig. 5(3):193–198.
   PubMed Web of Science ®Google Scholar
• Jha MK, Minhajuddin A, Gadad BS, Chin Fatt C, Trivedi MH. 2019. Higher S100B levels predict persistently elevated anhedonia with escitalopram monotherapy versus antidepressant combinations: findings from CO-MED trial. Pharmaceuticals. 12(4):184.
   Web of Science ®Google Scholar
• Kabukçu Başay B, Başay Ö, Tanriverdi Ç, Tunç-Ata M, Aydin SÜ. 2021. Elevated serum S100B levels in medication naïve children and adolescents with obsessive-compulsive disorder. Nord J Psychiatry. 75:502–508.
   PubMed Web of Science ®Google Scholar
• Kim JK, Kim SG, Kim HJ, Song YR. 2012. Serum S100B protein is associated with depressive symptoms in patients with end-stage renal disease. Clin Biochem. 45(18):1573–1577.
   PubMed Web of Science ®Google Scholar
• Kranaster L, Janke C, Mindt S, Neumaier M, Sartorius A. 2014. Protein S-100 and neuron-specific enolase serum levels remain unaffected by electroconvulsive therapy in patients with depression. J Neural Transm. 121(11):1411–1415.
   PubMed Web of Science ®Google Scholar
• Maier H, Helm S, Toto S, Moschny N, Sperling W, Hillemacher T, Kahl KG, Jakubovski E, Bleich S, Frieling H, et al. 2018. S100B, homocysteine, vitamin B12, folic acid, and procalcitonin serum levels in remitters to electroconvulsive therapy: a pilot study. Dis Markers. 2018:1–8.
   Web of Science ®Google Scholar
• O'Connell K, Thakore J, Dev KK. 2013. Levels of S100B are raised in female patients with schizophrenia. BMC Psychiatry. 13:146.
   PubMed Web of Science ®Google Scholar
• Oris C, Pereira B, Durif J, Simon-Pimmel J, Castellani C, Manzano S, Sapin V, Bouvier D. 2018. The biomarker S100B and mild traumatic brain injury: a meta-analysis. Pediatrics. 141(6):e20180037.
   PubMed Web of Science ®Google Scholar
• Palmio J, Huuhka M, Laine S, Huhtala H, Peltola J, Leinonen E, Suhonen J, Keränen T. 2010. Electroconvulsive therapy and biomarkers of neuronal injury and plasticity: serum levels of neuron-specific enolase and S-100b protein. Psychiatry Res. 177(1–2):97–100.
   PubMed Web of Science ®Google Scholar
• Papmeyer M, Giles S, Sussmann JE, Kielty S, Stewart T, Lawrie SM, Whalley HC, McIntosh AM. 2015. Cortical thickness in individuals at high familial risk of mood disorders as they develop major depressive disorder. Biol Psychiatry. 78(1):58–66.
   PubMed Web of Science ®Google Scholar
• Papuć E, Rejdak K. 2020. Increased cerebrospinal fluid S100B and NSE reflect neuronal and glial damage in Parkinson’s disease. Front Aging Neurosci. 12:156.
   PubMed Web of Science ®Google Scholar
• Pearlman DM, Brown JR, MacKenzie TA, Hernandez F, Najjar S. 2014. Blood levels of S-100 calcium-binding protein B, high-sensitivity C-reactive protein, and interleukin-6 for changes in depressive symptom severity after coronary artery bypass grafting: prospective cohort nested within a randomized, controlled trial. PLOS One. 9(10):e111110.
   PubMed Web of Science ®Google Scholar
• Portella MJ, de Diego-Adeliño J, Gómez-Ansón B, Morgan-Ferrando R, Vives Y, Puigdemont D. 2011. Ventromedial prefrontal spectroscopic abnormalities over the course of depression: a comparison among first episode, remitted recurrent and chronic patients. J Psychiatr Res. 45:427–434.
   PubMed Web of Science ®Google Scholar
• R Core Team. 2021. R: a language and environment for statistical computing. https://www.r-project.org/.
   Google Scholar
• Rajewska-Rager A, Dmitrzak-Weglarz M, Kapelski P, Lepczynska N, Pawlak J, Twarowska-Hauser J, et al. 2021. Longitudinal assessment of S100B serum levels and clinical factors in youth patients with mood disorders. Sci Rep. 11:11973.
   PubMed Web of Science ®Google Scholar
• Rajkowska G, Stockmeier C. 2013. Astrocyte pathology in major depressive disorder: insights from human postmortem brain tissue. Curr Drug Targets. 14(11):1225–1236.
   PubMed Web of Science ®Google Scholar
• Rezaei F, Abbasi H, Sadeghi M, Imani MM. 2020. The effect of obstructive sleep apnea syndrome on serum S100B and NSE levels: a systematic review and meta-analysis of observational studies. BMC Pulm Med. 20(1):31.
   PubMed Web of Science ®Google Scholar
• Rothermundt M, Arolt V, Wiesmann M, Missler U, Peters M, Rudolf S, Kirchner H. 2001. S-100B is increased in melancholic but not in non-melancholic major depression. J Affect Disord. 66(1):89–93.
   PubMed Web of Science ®Google Scholar
• Rothermundt M, Ponath G, Glaser T, Hetzel G, Arolt V. 2004. S100B serum levels and long-term improvement of negative symptoms in patients with schizophrenia. Neuropsychopharmacology. 29(5):1004–1011.
   PubMed Web of Science ®Google Scholar
• Rothoerl RD, Woertgen C, Brawanski A. 2000. S-100 serum levels and outcome after severe head injury. In: Mendelow AD, Baethmann A, Czernicki Z, editors. Brain Edema XI. Acta Neurochirurgica Supplements, vol 76. Vienna: Springer-Verlag; p. 97–100.
   Google Scholar
• Schäfer BW, Heizmann CW. 1996. The S100 family of EF-hand calcium-binding proteins: functions and pathology. Trends Biochem Sci. 21(4):134–140.
   PubMed Web of Science ®Google Scholar
• Schmidt FM, Mergl R, Stach B, Jahn I, Schönknecht P. 2015. Elevated levels of cerebrospinal fluid neuron-specific enolase (NSE), but not S100B in major depressive disorder. World J Biol Psychiatry. 16(2):106–113.
   PubMed Web of Science ®Google Scholar
• Schroeter ML, Abdul-Khaliq H, Krebs M, Diefenbacher A, Blasig IE. 2008. Serum markers support disease-specific glial pathology in major depression. J Affect Disord. 111(2–3):271–280.
   PubMed Web of Science ®Google Scholar
• Schroeter ML, Abdul-Khaliq H, Krebs M, Diefenbacher A, Blasig IE. 2009. Neuron-specific enolase is unaltered whereas S100B is elevated in serum of patients with schizophrenia-original research and meta-analysis. Psychiatry Res. 167(1–2):66–72.
   PubMed Web of Science ®Google Scholar
• Schroeter ML, Steiner J, Mueller K. 2011. Glial pathology is modified by age in mood disorders-a systematic meta-analysis of serum S100B in vivo studies . J Affect Disord. 134(1–3):32–38.
   PubMed Web of Science ®Google Scholar
• Schroeter ML, Abdul-Khaliq H, Diefenbacher A, Blasig IE. 2002. S100B is increased in mood disorders and may be reduced by antidepressive treatment. Neuroreport. 13:1675–1678.
   PubMed Web of Science ®Google Scholar
• Si X, Miguel-Hidalgo JJ, O'Dwyer G, Stockmeier CA, Rajkowska G. 2004. Age-dependent reductions in the level of glial fibrillary acidic protein in the prefrontal cortex in major depression. Neuropsychopharmacology. 29(11):2088–2096.
   PubMed Web of Science ®Google Scholar
• Steiner J, Bernstein H-G, Bielau H, Berndt A, Brisch R, Mawrin C, Keilhoff G, Bogerts B. 2007. Evidence for a wide extra-astrocytic distribution of S100B in human brain. BMC Neurosci. 8:2.
   PubMed Web of Science ®Google Scholar
• Treadway MT, Waskom ML, Dillon DG, Holmes AJ, Park MTM, Chakravarty MM, Dutra SJ, Polli FE, Iosifescu DV, Fava M, et al. 2015. Illness progression, recent stress, and morphometry of hippocampal subfields and medial prefrontal cortex in major depression. Biol Psychiatry. 77(3):285–294.
   PubMed Web of Science ®Google Scholar
• Tsai M-C, Huang T-L. 2016. Increased activities of both superoxide dismutase and catalase were indicators of acute depressive episodes in patients with major depressive disorder. Psychiatry Res. 235:38–42.
   PubMed Web of Science ®Google Scholar
• WHO. 2020. Depression. Fact sheets [Internet]. https://www.who.int/news-room/fact-sheets/detail/depression.
   Google Scholar
• Wiesmann M, Wandinger KP, Missler U, Eckhoff D, Rothermundt M, Arolt V, Kirchner H. 1999. Elevated plasma levels of S-100b protein in schizophrenic patients. Biol Psychiatry. 45(11):1508–1511.
   PubMed Web of Science ®Google Scholar
• Yang K, Xie G-R, Hu Y-Q, Mao F-Q, Su L-Y. 2008. The effects of gender and numbers of depressive episodes on serum S100B levels in patients with major depression. J Neural Transm. 115(12):1687–1694.
   PubMed Web of Science ®Google Scholar
• Zachrisson OC, Balldin J, Ekman R, Naesh O, Rosengren L, Agren H, Blennow K. 2000. No evident neuronal damage after electroconvulsive therapy. Psychiatry Res. 96(2):157–165.
   PubMed Web of Science ®Google Scholar